A pioneering new treatment promises to tackle a wider range of cancers, with fewer side-effects than conventional ...

Johnson & Johnson , fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular , reported fourth-quarter ...

Kirk Herbstreit wasn’t able to hold back his emotions after Ohio State won the national championship on Monday night at ...

The cancer mortality rate continued to decline but increases in cancer in young people, women and populations of color are ...

Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

ESPN analyst Kirk Herbstreit was visibly emotional after his alma mater Ohio State defeated Notre Dame to win the national ...

Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...

A man who shrank by three inches after developing a rare cancer has thanked a UK-leading team for extending his life. Peter ...

WASHINGTON — President Trump unveiled a $500 billion artificial intelligence infrastructure project Tuesday at the White ...

Atara Biotherapeutics said on Tuesday the U.S. health regulator has placed a clinical hold on its trials for cancer cell ...

Larry Ellison unveiled plans for an AI-driven cancer vaccine system that could deliver personalized treatments within 48 ...

Work to create a dedicated cancer hospital in Cambridge could begin this year, the government announced. Cambridge Cancer ...